~~<i id='2148A4A550'><strike id='2148A4A550'><tt id='2148A4A550'><pre id='2148A4A550'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：leisure time 2025-08-11 11:46:03 - browse：633

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： ADCs take center stage as promising cancer treatments

explore

leisure time

focus

hotspot

entertainment

hotspot

Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde

WSS

ADCs take center stage as promising cancer treatments

STAT Summit: The economic case for universal basic health care

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Roche acquires Telavant from Roivant, adding experimental IBD treatment

A new nitrogen execution bill also undermines medical licensing

STAT Summit: Meghan O’Rourke on making chronic illness visible

entertainment

Wikipedia

explore

Affirmative action in medical school literally saved lives

STAT Summit: The economic case for universal basic health care

Medical leaders decry Supreme Court decision on affirmative action

The problems with dementia villages

Wildfire smoke exposes gaps in outdoor worker protections

A new nitrogen execution bill also undermines medical licensing

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Supreme Court strikes down use of affirmative action

FDA clears Verve to begin U.S. study of gene

leisure time

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

The Harvard botanist who searched for psychedelics in the Amazon

A new nitrogen execution bill also undermines medical licensing

UnitedHealth, Optum discontinue NaviHealth name

Ed Silverman on new gene therapies, biosimilars, coffee, and more

The problems with dementia villages

focus

hotspot

entertainment

hotspot